1. Home
  2. AIMD

as of 12-24-2025 12:36pm EST

$1.99
+$0.01
+0.40%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.

Founded: 1984 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 10.2M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 24.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -4.06 EPS Growth: N/A
52 Week Low/High: $1.78 - $5.00 Next Earning Date: 11-13-2025
Revenue: $113,037 Revenue Growth: 178.19%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered AIMD Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 21 hours ago

AI Recommendation

hold
Model Accuracy: 65.33%
65.33%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: